Skip to main content

Table 2 Evaluation of clinicopathological characteristics in the subgroup analysis of OS

From: Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan

  1. Ref Reference; P-value: Fisher’s exact test, and the value of the comparison between this group and other groups
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us